IU Medical Group's quality improvement goals are to decrease mortality and morbidity, increase patient satisfaction, improve patient safety, and link these goals to management accountability. Metrics such as UHC reports and patient satisfaction surveys are used to measure progress. Clinical department chairs must annually report progress on these goals to the board. The organization utilizes numerous quality reports and surveys to measure and improve patient care. Each clinical department is responsible for quality and safety programs within their department.
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
This workshop will look at patient care pathways and demonstrate how simulation can combine process flow across; services, clinical best practice and the progression of patients through disease states, to test the impact of improvement initiatives on patient care, outcomes, costs and resource utilization.
Using examples from recent projects on simulating care pathways within HIV services, and simulating future service needs for dementia care, we show the results of combining disease progression with service utilization.
In the workshop, we’ll consider what the ideal pathway model would look like and invite you to work with us to build a pathway using our latest technology.
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsViewics
As US healthcare systems grapple with the recent upheavals in care payment and delivery, they are turning to advanced analytics as their “central nervous systems” for driving care and financial performance.
Laboratory information — spanning chemistry, pathology, microbiology and molecular testing, for example — is among the best sources of data for these advanced analytics, including clinician decision support, predictive analytics, population health management, and personalized medicine. When strategically harnessed and integrated to create a patient-centric lab data lake, laboratory information can form an affordable yet competitively powerful advanced analytics solution well suited for many health systems — i.e., a disruptive option.
L. Eleanor J. Herriman, MD, MBA, Chief Medical Informatics Officer of Viewics, explains why laboratory data should be a core strategic component for achieving success in value-based healthcare.
Introduction of the NZ Health IT Plan enables better gout management - Reflections of an early adopter. Presented by Peter Gow, Counties Manukau DHB, at HINZ 2014, 12 November 2014, 11.37am, Plenary Room
This workshop will look at patient care pathways and demonstrate how simulation can combine process flow across; services, clinical best practice and the progression of patients through disease states, to test the impact of improvement initiatives on patient care, outcomes, costs and resource utilization.
Using examples from recent projects on simulating care pathways within HIV services, and simulating future service needs for dementia care, we show the results of combining disease progression with service utilization.
In the workshop, we’ll consider what the ideal pathway model would look like and invite you to work with us to build a pathway using our latest technology.
Advanced Laboratory Analytics — A Disruptive Solution for Health SystemsViewics
As US healthcare systems grapple with the recent upheavals in care payment and delivery, they are turning to advanced analytics as their “central nervous systems” for driving care and financial performance.
Laboratory information — spanning chemistry, pathology, microbiology and molecular testing, for example — is among the best sources of data for these advanced analytics, including clinician decision support, predictive analytics, population health management, and personalized medicine. When strategically harnessed and integrated to create a patient-centric lab data lake, laboratory information can form an affordable yet competitively powerful advanced analytics solution well suited for many health systems — i.e., a disruptive option.
L. Eleanor J. Herriman, MD, MBA, Chief Medical Informatics Officer of Viewics, explains why laboratory data should be a core strategic component for achieving success in value-based healthcare.
Hospital Committees are regular standing committees prescribed by regulatory agencies and deemed necessary by hospital administration in formulating policies, coordinating and monitoring hospital-wide activities that are considered critical in the delivery of quality health care services.
These are in contrast to ad hoc committees, department and unit committees.
Revolutionizing Renal Care With Predictive Analytics for CKDViewics
Chronic Kidney Disease (CKD) is a common and growing condition, affecting about half of the Medicare population and of diabetics. In the United States, the lifetime risk of CKD for 30-year-olds is now greater than half, and the prevalence of CKD is projected to rise significantly over the next 15 years.
Current methods of predicting which CKD patients will progress to renal failure and require dialysis or transplant have low accuracy rates, causing great anxiety and suboptimal care. Without accurate risk prediction, many patients are over-treated, effectively wasting limited resources and negatively impacting outcomes. Conversely, other patients may receive inadequate treatment, restricting options to only the most costly and least desirable interventions.
Watch this on-demand webinar with Dr. Navdeep Tangri, developer of the Kidney Failure Risk Equation, which revolutionizes the way CKD patients are managed by leveraging laboratory data to accurately predict the risk of kidney failure in patients with CKD.
You’ll learn:
• How CKD is burdening our healthcare system, and the need for better care management tools
• How the Kidney Failure Risk Equation was researched, developed, and validated
• How Viewics is implementing CKD predictive analytics to automatically deliver risk information to clinicians and issue customized, educational reports to patients and clinicians
Advanced Lab Analytics for Patient Blood Management ProgramsViewics
Reports indicate that 30 – 70% of blood transfusions are inappropriate. Inappropriate blood transfusions put patients at increased risk of post-surgical infections, multi-system organ failure, longer hospital stays, and higher mortality rates. The transfusion guidelines most clinicians learned in their training are now outdated. As such, blood transfusion practices vary widely, and overutilization remains a major quality and cost problem.
Patient Blood Management (PBM) programs are designed to optimize the use of transfusions through a team-based approach, evidence-based guidelines, and algorithms that together guide decisions regarding specifically which patients and clinical procedures warrant blood products, and how much to transfuse. PBM programs have been quite successful in improving patient morbidity and mortality outcomes and generating millions of dollars in savings for hospitals.
Laboratory analytics can be an effective means of instituting restrictive transfusion programs, and advanced lab analytics can be critical in implementing PBM programs, as lab testing and tracking blood usage is central to decision making, changing behavior, and improving performance.
Watch a presentation by Dr. Eleanor Herriman, Chief Medical Informatics Officer at Viewics. She unveils a new suite of advanced analytics tools that support PBS and other restrictive blood management programs, enabling health systems to better leverage their valuable lab medicine assets and fully integrate this key service line into these programs.
You’ll learn:
• How inappropriate blood transfusions are burdening our healthcare system, and the need for better utilization management tools
• New guidelines restricting red blood cell transfusions
• The role of advanced lab analytics in PBM programs
• How Viewics is leveraging advanced lab analytics to help health systems more easily and cost-effectively implement PBM programs
A review of the total knee replacement pathway: Integrated care is quality careApollo Hospitals
A Total Knee Replacement (TKR) Pathway (adapted from the Credit Valley Hospital, Canada) is in place at the Apollo Health city facility since 2011. We re-visited the pathway design and the priority grid that led to its adaptation. We analyzed the data with the aim to analyze repetitive and unique trends and evaluate the performance of the pathway. Even with the increased volume the patient satisfaction rose from 56% at the time of pathway implementation to 77% at the end of the evaluation period of 45 months. The Average Length of Stay reduced by 27% from 7.94 to 5.78 days (the difference between the initial and final recorded values), in the same evaluation time period. The methodology of evaluation of the pathway was adapted from the Leuven Clinical Pathway Compass 5 way approach.
Best Practices for a Data-driven Approach to Test UtilizationViewics
Would you like to learn how data-driven interventions can improve laboratory test utilization in your organization? Would you like to hear about the impact that leading hospitals/health systems and managed care organizations have made through these interventions?
If so, you might be interested in this presentation by utilization management expert Dr. Michael Astion, Medical Director at the Department of Laboratories at Seattle Children’s Hospital and Clinical Professor of Laboratory Medicine at the University of Washington.
In this presentation, Dr. Astion discusses the current state of the misuse of laboratory testing in the United States and some of the interventions that are being implemented to improve it. He covers a number of common areas of unnecessary testing — from pure abuse to tests that could be useful but are ordered inappropriately.
You'll learn about:
• Two areas of laboratory testing where misordering of tests occur frequently
• Three interventions to improve the value of testing for patients
• The role of genetic counselors and other laboratory professionals in improving lab test ordering
• The national endeavor known as PLUGS, the Pediatric Laboratory Utilization Guidance Service
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
An Orientation to quality and patient safety for new hire in health care faci...kiran
An introduction to quality and patient safety for new employees in health care with basic concepts on quality and patient safety that every new hire must know.
Clinical practice guidelines are “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”They are intended to offer concise instructions on how to provide healthcare services.The most important benefit of clinical practice guidelines is their potential to improve both the quality or process of care and patient outcomes. Increasingly, clinicians and clinical managers must choose from numerous, sometimes differing, and occasionally contradictory, guidelines.
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
The United States healthcare system has a serious infectious disease management problem. The antibiotic resistance crisis is widespread, serious, costly, and deadly. Delays in pathogen identification lead to poor clinical outcomes, including increased mortality risk. And, optimally managing outbreaks is critical to health systems whose reimbursement is tied to the health of a population, such as ACOs.
Eleanor Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics led an informative panel discussion with industry leaders on the issues surrounding the infectious disease management crisis. Margret Oethinger, MD, Ph.D., Medical Director of Providence Health & Services, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories, Department of Pathology, Kaiser Permanente and President-Elect, American Society for Microbiology cover the current state of infectious disease management in the U.S., and what can be done to improve it.
You’ll learn about:
• The magnitude of the U.S. health system’s infectious disease management problem
• The most serious concerns and trends for healthcare institutions and communities across the nation
• The most promising solutions to health systems’ most urgent infectious disease management challenges
Breakout 4. 2 Benefits of implementing medicines optimisation in a COPD and a...NHS Improvement
Breakout 4. 2 Benefits of implementing medicines optimisation in a COPD and asthma clinic - Clare Watson
Medicines Management Pharmacist (NHS Hampshire)
Independent Prescriber (Victoria Practice, Aldershot)
Part of a set of presentations from NHS Improvement event: Better value, better outcomes held on Thursday 21 February 2013,
Guoman Tower Hotel, London
How to deliver quality and value in chronic care:sharing the learning from the respiratory programme
Hospital Committees are regular standing committees prescribed by regulatory agencies and deemed necessary by hospital administration in formulating policies, coordinating and monitoring hospital-wide activities that are considered critical in the delivery of quality health care services.
These are in contrast to ad hoc committees, department and unit committees.
Revolutionizing Renal Care With Predictive Analytics for CKDViewics
Chronic Kidney Disease (CKD) is a common and growing condition, affecting about half of the Medicare population and of diabetics. In the United States, the lifetime risk of CKD for 30-year-olds is now greater than half, and the prevalence of CKD is projected to rise significantly over the next 15 years.
Current methods of predicting which CKD patients will progress to renal failure and require dialysis or transplant have low accuracy rates, causing great anxiety and suboptimal care. Without accurate risk prediction, many patients are over-treated, effectively wasting limited resources and negatively impacting outcomes. Conversely, other patients may receive inadequate treatment, restricting options to only the most costly and least desirable interventions.
Watch this on-demand webinar with Dr. Navdeep Tangri, developer of the Kidney Failure Risk Equation, which revolutionizes the way CKD patients are managed by leveraging laboratory data to accurately predict the risk of kidney failure in patients with CKD.
You’ll learn:
• How CKD is burdening our healthcare system, and the need for better care management tools
• How the Kidney Failure Risk Equation was researched, developed, and validated
• How Viewics is implementing CKD predictive analytics to automatically deliver risk information to clinicians and issue customized, educational reports to patients and clinicians
Advanced Lab Analytics for Patient Blood Management ProgramsViewics
Reports indicate that 30 – 70% of blood transfusions are inappropriate. Inappropriate blood transfusions put patients at increased risk of post-surgical infections, multi-system organ failure, longer hospital stays, and higher mortality rates. The transfusion guidelines most clinicians learned in their training are now outdated. As such, blood transfusion practices vary widely, and overutilization remains a major quality and cost problem.
Patient Blood Management (PBM) programs are designed to optimize the use of transfusions through a team-based approach, evidence-based guidelines, and algorithms that together guide decisions regarding specifically which patients and clinical procedures warrant blood products, and how much to transfuse. PBM programs have been quite successful in improving patient morbidity and mortality outcomes and generating millions of dollars in savings for hospitals.
Laboratory analytics can be an effective means of instituting restrictive transfusion programs, and advanced lab analytics can be critical in implementing PBM programs, as lab testing and tracking blood usage is central to decision making, changing behavior, and improving performance.
Watch a presentation by Dr. Eleanor Herriman, Chief Medical Informatics Officer at Viewics. She unveils a new suite of advanced analytics tools that support PBS and other restrictive blood management programs, enabling health systems to better leverage their valuable lab medicine assets and fully integrate this key service line into these programs.
You’ll learn:
• How inappropriate blood transfusions are burdening our healthcare system, and the need for better utilization management tools
• New guidelines restricting red blood cell transfusions
• The role of advanced lab analytics in PBM programs
• How Viewics is leveraging advanced lab analytics to help health systems more easily and cost-effectively implement PBM programs
A review of the total knee replacement pathway: Integrated care is quality careApollo Hospitals
A Total Knee Replacement (TKR) Pathway (adapted from the Credit Valley Hospital, Canada) is in place at the Apollo Health city facility since 2011. We re-visited the pathway design and the priority grid that led to its adaptation. We analyzed the data with the aim to analyze repetitive and unique trends and evaluate the performance of the pathway. Even with the increased volume the patient satisfaction rose from 56% at the time of pathway implementation to 77% at the end of the evaluation period of 45 months. The Average Length of Stay reduced by 27% from 7.94 to 5.78 days (the difference between the initial and final recorded values), in the same evaluation time period. The methodology of evaluation of the pathway was adapted from the Leuven Clinical Pathway Compass 5 way approach.
Best Practices for a Data-driven Approach to Test UtilizationViewics
Would you like to learn how data-driven interventions can improve laboratory test utilization in your organization? Would you like to hear about the impact that leading hospitals/health systems and managed care organizations have made through these interventions?
If so, you might be interested in this presentation by utilization management expert Dr. Michael Astion, Medical Director at the Department of Laboratories at Seattle Children’s Hospital and Clinical Professor of Laboratory Medicine at the University of Washington.
In this presentation, Dr. Astion discusses the current state of the misuse of laboratory testing in the United States and some of the interventions that are being implemented to improve it. He covers a number of common areas of unnecessary testing — from pure abuse to tests that could be useful but are ordered inappropriately.
You'll learn about:
• Two areas of laboratory testing where misordering of tests occur frequently
• Three interventions to improve the value of testing for patients
• The role of genetic counselors and other laboratory professionals in improving lab test ordering
• The national endeavor known as PLUGS, the Pediatric Laboratory Utilization Guidance Service
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
An Orientation to quality and patient safety for new hire in health care faci...kiran
An introduction to quality and patient safety for new employees in health care with basic concepts on quality and patient safety that every new hire must know.
Clinical practice guidelines are “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”They are intended to offer concise instructions on how to provide healthcare services.The most important benefit of clinical practice guidelines is their potential to improve both the quality or process of care and patient outcomes. Increasingly, clinicians and clinical managers must choose from numerous, sometimes differing, and occasionally contradictory, guidelines.
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
The United States healthcare system has a serious infectious disease management problem. The antibiotic resistance crisis is widespread, serious, costly, and deadly. Delays in pathogen identification lead to poor clinical outcomes, including increased mortality risk. And, optimally managing outbreaks is critical to health systems whose reimbursement is tied to the health of a population, such as ACOs.
Eleanor Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics led an informative panel discussion with industry leaders on the issues surrounding the infectious disease management crisis. Margret Oethinger, MD, Ph.D., Medical Director of Providence Health & Services, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories, Department of Pathology, Kaiser Permanente and President-Elect, American Society for Microbiology cover the current state of infectious disease management in the U.S., and what can be done to improve it.
You’ll learn about:
• The magnitude of the U.S. health system’s infectious disease management problem
• The most serious concerns and trends for healthcare institutions and communities across the nation
• The most promising solutions to health systems’ most urgent infectious disease management challenges
Breakout 4. 2 Benefits of implementing medicines optimisation in a COPD and a...NHS Improvement
Breakout 4. 2 Benefits of implementing medicines optimisation in a COPD and asthma clinic - Clare Watson
Medicines Management Pharmacist (NHS Hampshire)
Independent Prescriber (Victoria Practice, Aldershot)
Part of a set of presentations from NHS Improvement event: Better value, better outcomes held on Thursday 21 February 2013,
Guoman Tower Hotel, London
How to deliver quality and value in chronic care:sharing the learning from the respiratory programme
Artificial intelligence (AI) is everywhere, promising self-driving cars, medical breakthroughs, and new ways of working. But how do you separate hype from reality? How can your company apply AI to solve real business problems?
Here’s what AI learnings your business should keep in mind for 2017.
Study: The Future of VR, AR and Self-Driving CarsLinkedIn
We asked LinkedIn members worldwide about their levels of interest in the latest wave of technology: whether they’re using wearables, and whether they intend to buy self-driving cars and VR headsets as they become available. We asked them too about their attitudes to technology and to the growing role of Artificial Intelligence (AI) in the devices that they use. The answers were fascinating – and in many cases, surprising.
This SlideShare explores the full results of this study, including detailed market-by-market breakdowns of intention levels for each technology – and how attitudes change with age, location and seniority level. If you’re marketing a tech brand – or planning to use VR and wearables to reach a professional audience – then these are insights you won’t want to miss.
Top seven healthcare outcome measures of healthJosephMtonga1
The seven healthcare outcome measures are meant to understand the quality of health systems and how they could be measured and how quality care could be provided to clients.
Public Reporting as a Catalyst for Better Consumer DecisionsATLAS Conference
Greater efficiency in the process of matching patients to appropriate providers is vital to achieving the Triple Aim. As patients research and choose among appropriate providers, sound decision-making will depend on the accessibility of high-quality data that enables them to make meaningful, actionable comparisons. Online public-reporting tools, such as those published by U.S. News, CMS and others, serve as venues for consumer decision-making. Driven by current trends in data transparency, rapid advances in public reporting can be anticipated. This presentation will outline several recent and expected future developments in the evolution of key public-reporting tools, and discuss their role in facilitating patient engagement and access to appropriate care.
Rob Reid: Redesigning primary care: the Group Health journeyThe King's Fund
Rob Reid, Senior Investigator at Group Health Research Institute, explains the journey taken by Group Health in support of integrated primary care. A case study in how primary care can be delivered effectively and efficiently to a population, Rob laid out the challenges facing general practice in the States, and how Group Health worked to improve the situation for both patients and the workforce.
Infection Prevention Practices on the Healthcare Frontier: Emerging Models of...bden129
Describes growth in ambulatory/outpatient care across broad specialties and in varied settings including micro-hospitals,
ambulatory surgery centers, freestanding emergency departments, urgent care, and other locations.
Quality and safety, Vision 2025, Specific challenges of Nursing on quality, Quality improvement division, Fish bone technique,QI model, PDCA, Role of Nurse, Empowerment, Nursing positioning and policies,
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...edbkline
Clinical results from application of paper-based medical error reduction/compliance program vs software-based MERP program implenented at 30 free-standing radiation oncology centers.
2. What are the goals of IU Medical Group’s quality improvement
program? What metrics and benchmarks are used to measure
progress towards each of these performance goals? How is each
goal specifically linked to management accountability?
IU Medical Group’s goals for our patients are to:
• Decrease Mortality
• Decrease Morbidity
• Increase Patient Satisfaction
• Improve Patient Safety
• IU Medical Group utilizes the University Healthcare
Consortium for benchmarks in mortality, morbidity and
safety. Our patient satisfaction information utilizes the
Regenstrief organization, and the Pickar survey.
• Each Clinical Chair will be asked to report their
departments progress on these goals to the Board at
least annually.
4. Where we are now…
UHC Results for IU Hospital
2007 Rank 2008 Goal
Mortality (35%) 17 12-15
Effectiveness (35%) 62 25-30
Safety (20%) 6 3-5
• In 2007 Methodist ranked #1 in the UHC database out of all Academic
Medical Centers
• IU Hospital moved up to #29 with the addition of the latest quarter.
• IU Hospital was among the most improved of all the 82 hospitals evaluated.
5.
6. How does IU measure and improve the quality of
patient care? Who are the key management and clinical
leaders responsible for these quality and safety
programs?
IU Medical Group measures and improves the quality of patient care
with the following metrics:
• UHC Reports:
– Quality and Safety Management Report (QSMR)
– Hospital Quality Measures Report (HQMR)
– Clinical Outcomes Report
– Key Indicator Report
– Quality and Accountability Report
• Patient and Referring Physician Satisfaction Surveys
• Clarian Quality Matrix
• Wishard Hospital Incentive Program
• Each of the 19 clinical departments are responsible for ensuring the
quality and safety of their departments.
8. Quality Matrix Items--Improvements
• Success stories
– Surgical Quality Committee
• Reducing complications, mortality & readmissions
• Improving patient throughput
• Beginning to use NSQIP risk adjusted data
– Central line blood stream infection teams in progress
– UHC Palliative Care Benchmarking Study
– Clinical Documentation Improvement Program
– Engagement of Department of Medicine
9. Case example
Surgical - Complications of anesthesia - Adults (Rate per 1000)
AHRQ
• Definition: Cases of anesthetic overdose, reaction, or endotrachial
tube misplacement per 1,000 surgery discharges.
• Denominator: All surgical discharges 18 years and older or MDC 14
defined by specific DRGs. Exclude patients with codes for poisoning
due to anesthetics (E8551, 9681-4, 9687) and any diagnosis code
for active drug dependence,
• active non-dependent abuse of drugs, or self-inflicted injury.
• Numerator: Discharges with ICD-9-CM diagnosis codes for
anesthesia complications in any secondary diagnosis field per 1,000
discharges.
• Target: AHRQ expected rate (O/E ratio of 1.0). Rank and Top-10
based on O/E ratios.
11. How are IU’s quality assessment and improvement processes integrated
into overall corporate policies and operations? Are clinical quality
standards supported by operational policies? How does management
implement and enforce these policies? What internal controls exist to
monitor and report on quality metrics?
• Our faculty adheres to the policy and procedures of the
health care entities in which they practice. These
include, but are not limited to Clarian’s downtown
hospitals, Wishard Health System, the Roudebush VA
Medical Center, Clarian West, and Clarian North.
• The Compliance Committee of the IU School of Medicine
enforces the compliance of the practices of the school.
• The IUMG Credentialing Committee credentials all IUMG
providers.
• The Medical Management Committee of IUMG SC has
been charged by the IUMG – SC Board to develop,
implement, and review all the quality and safety activities
of the organization.
12. IU Medical Group – Specialty Care
Medical Management Committee
July 17, 2008
NEXT MEETING: Thursday, August 21st, 2008, Medical Sciences Building, Daly Center 122C-D
Herbert Cushing MD MS 164 Bill Wooden MD EH 232 Jeffrey M. Rothenberg
MD
UH 2440 David Kovach MD FH 204
David Crabb M.D EH 317 Michael A. Kraus MD UH 1115 Daniel A. Rushing MD RT 473 Deanna Willis MD LO
200
Lisa Hancock RN LO 401 Richard T. Miyamoto M.D RI 0860 Mike Ober MD UH 2100 Keith Lillemoe MD EH
203
John Fitzgerald LO 401 Darrell WuDunn MD RO 301 David Posey MD ROC
4300
Henry Pitt MD RT
130d
Val Jackson MD UH0663 Michael Lykens MD EH 312 Steve Hugenberg MD LO 545
Agenda Item
PQRI results for IUMG
-Jan through May 2008
Policy Review
-Identification and Monitoring of Quality Issues
-Ongoing Monitoring of Complaints and Quality Issues
Regenstrief Survey Results
Jul ’06-Jan ‘08
Credentials Committee 2nd Quarter 2008 Results
Health Care Notification Network Overview
13. Does the IUMG board have a formal orientation and
continuing education process that helps members
appreciate external quality and patient safety
requirements? Does the board include members with
expertise in patient safety and quality improvement
issues?
• The IUMG – SC Medical Director meets with each of the
Department Chairs, or their designee to share and
review the departments quality and safety data and
develop improvement plans when necessary.
• The IUMG – SC Board includes members with expertise
in patient quality and safety.
14. Physician Education and Training
Partnership between Medical Education, IUSOM, & Quality
Residents, Faculty, New medical staff, & Medical students.
Orientations for all new interns, 3rd
year med students, new
faculty on staff.
Ongoing training with quality and safety lunches,
intersessions for med students, orientation for new faculty
mid-year.
Core curriculum
Quality, Safety, Medical Equipment, Cerner, Regulatory
Compliance, Infection Control, Medication Safety, etc.
Designed for orientation & on-going information sharing
15. What information is essential to the board’s ability to understand and
evaluate the organization’s quality assessment and performance
improvement programs? Once these performance metrics and
benchmarks are established, how frequently does the board receive
reports about the quality improvement efforts?
• The IUMG – SC Board requires each of the Clinical
Departments to report at least annually to report on the
following:
• Mortality
• Morbidity
• Satisfaction
• Safety
• CMS Physician Voluntary Reporting Program (PQRI)
• EMR implementation
• Communication with referring physicians and patients
16. Physician Quality Reporting Initiative (PQRI)
• PQRI establishes a financial incentive for eligible professionals to
participate in a voluntary quality reporting program. Eligible
professionals who successfully reported PQRI quality measures
may earn an incentive, of 1.5% of total allowed charges for covered
Medicare physician fee schedule services.
• If no more than three 2007 PQRI quality measures were applicable,
each measure must have been reported in at least 80% of the cases
in which the measure was reportable.
• 27,811 PQRI measures were reported on from July – December
2007
• 84% of those reported measures were for Medicare patients
• Anesthesia, Dermatology, Emergency Medicine, Primary Care,
Medicine, Ophthalmology, Orthopaedic Surgery, and Surgery
reported measures. These groups met the 30 minimum
patient/encounter episode to qualify for participation.
• 5% of the reported PQRI measures did not meet the performance
requirement.
17. PQRI Results Example
Anesthesia
• 19 providers reported:
• 819 Total patients were reported on that antibiotics
were given w/in 1 hour prior to surgery
– 717 Medicare patients (88% of the patients reported on)
– 453 Medicare patients had documentation that antibiotics
were given w/in 1 hour prior to surgery
• 63% of Medicare patients were given antibiotics w/in 1 hour prior
to surgery
• 36% of Medicare patients did not have the documentation that
antibiotics were given, but were successfully reported on.
18. Case example
Otolaryngology wanted to report on the following
CMS measures:
• Acute Otitis Externa-Topical Therapy (ages 2
and older)
• Acute Otitis Externa-Pain Assessment (ages 2
and older)
• Acute Otitis Externa-Systemic Antimicrobial
Therapy, Avoidance of Inappropriate Use (ages
2 and older)
19. Case example
• How many Medicare patients, age 2 or
greater have a diagnosis of Acute Otitis
Externa?
• How many Medicare patients, age 2
months to 12 years, have Otitis Media with
Effusion?
20. Case Example
Data query
• Otolaryngology PQRI Data Date: 5/9/08 Detail Filter: Group Department
Name - Txn = 'OTOLARYNGOLOGY' and Invoice DOS - Txn between
2007-04-12 and 2008-04-12 and Orig Pmt FSC Report Category 1 - Txn =
'MEDICARE' and ( DX1 ICD9-CM Code - Txn in ( '380.10' , '380.11' ,
'380.12' , '380.13' , '380.22' , '381.10' , '381.19' , '381.20' , '381.29' , '381.3' ,
'381.4' ) or DX2 ICD9-CM Code - Txn in ( '380.10' , '380.11' , '380.12' ,
'380.13' , '380.22' , '381.10' , '381.19' , '381.20' , '381.29' , '381.3' , '381.4' )
or DX3 ICD9-CM Code - Txn in ( '380.10' , '380.11' , '380.12' , '380.13' ,
'380.22' , '381.10' , '381.19' , '381.20' , '381.29' , '381.3' , '381.4' ) or DX4
ICD9-CM Code - Txn in ( '380.10' , '380.11' , '380.12' , '380.13' , '380.22' ,
'381.10' , '381.19' , '381.20' , '381.29' , '381.3' , '381.4' ) or DX5 ICD9-CM
Code - Txn in ( '380.10' , '380.11' , '380.12' , '380.13' , '380.22' , '381.10' ,
'381.19' , '381.20' , '381.29' , '381.3' , '381.4' ) or DX6 ICD9-CM Code - Txn
in ( '380.10' , '380.11' , '380.12' , '380.13' , '380.22' , '381.10' , '381.19' ,
'381.20' , '381.29' , '381.3' , '381.4' ) )
21. How does IU’s quality assessment and improvement
processes coordinated with its corporate compliance
program? How are quality of care and patient safety
issues addressed in the organization’s risk assessment
and corrective action plans?
• The IUMG faculty are integral to promoting corporate
compliance, as well as to risk management and
organizational reputation. All employees and faculty are
encouraged to use the confidential hotline numbers to
report compliance issues anonymously. The use of the
hotline is not limited to compliance, and can be used for
quality and safety concerns as well.
• IUMG collaborates with each of our hospital partners in
their risk assessment and corrective action programs
22. What processes are in place to promote the reporting
of quality concerns and medical errors and to protect
those who ask questions and report problems? What
guidelines exist for reporting quality and patient safety
concerns to the board?
• IUMG encourages all employees and faculty to utilize the
confidential compliance hotlines to report any issue.
This includes the University, Clarian, Wishard, and the
VA. All quality and safety issues are investigated by the
Medical Director, and are reviewed by the Medical
Management Committee, which reports to the IUMG –
SC Board. All such reports are handled in a confidential
manner.
23. Are human and other resources adequate to support
patient safety and clinical quality? How are proposed
changes in resource allocation evaluated from the
perspective of clinical quality and patient care? Are
systems in place to provide adequate resources to
account for differences in patient acuity and care
needs?
• Resources are assessed at least on an annual
basis. Our Board has recently allocated
additional resources for quality and safety.
• IUMG – SC utilizes the UHC case mix index to
benchmark the acuity of our patients.
24. Does IU’s competency assessment and training,
credentialing, and peer review processes adequately
recognize the necessary focus on clinical quality and
patient safety issues?
• IUMG – SC reviews malpractice complaints, the
National Practitioner Databank, patient
satisfaction, credentialing and physician specific
complaints. The Credentialing Committee and
the Medical Management Committee review and
act on this information and report to the Board.
25. How are “adverse patient events” and other medical
errors identified, analyzed, reported, and incorporated
into IU’s performance improvement activities? How do
management and the board address quality
deficiencies without unnecessarily increasing the
organization’s liability exposure?
• IUMG – SC is linked to the Risk Management
departments of each of our affiliated hospitals. We also
assist with the following:
• Indiana State Department of Health Reportable Events
• JCAHO Sentinal Events
• Internal investigations and Reviews of adverse events
26. Questions?
Lisa Hancock, RN, MHA
Director of Quality Care
IU Medical Group - Specialty Care
ph. 317-278-9907
fax 317-278-9926
lcox@iupui.edu